Fassett Robert G, Driver Ritza, Healy Helen, Ranganathan Dwarakanathan, Ratanjee Sharad, Robertson Iain K, Geraghty Dominic P, Sharman James E, Coombes Jeff S
Renal Research, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
BMC Nephrol. 2009 Mar 12;10:8. doi: 10.1186/1471-2369-10-8.
Patients on peritoneal and hemodialysis have accelerated atherosclerosis associated with an increase in cardiovascular morbidity and mortality. The atherosclerosis is associated with increased arterial stiffness, endothelial dysfunction and elevated oxidative stress and inflammation. The aims of this study are to investigate the effects of peritoneal and hemodialysis on arterial stiffness, vascular function, myocardial structure and function, oxidative stress and inflammation in incident patients with end stage kidney disease.
This is an observational study. Eighty stage five CKD patients will be enrolled and followed for one-year. Primary outcome measures will be changes in 1) arterial stiffness measured by aortic pulse wave velocity, 2) oxidative stress assessed by plasma F2 isoprostanes and 3) inflammation measured by plasma pentraxin-3. Secondary outcomes will include additional measures of oxidative stress and inflammation, changes in vascular function assessed using the brachial artery reactivity technique, carotid artery intimal medial thickness, augmentation index and trans thoracic echocardiography to assess left ventricular geometry, and systolic and diastolic function. Patients will undergo these measures at baseline (6-8 weeks prior to starting dialysis therapy), then at six and 12 months after starting dialysis.
The results of this study may guide the choice of dialysis modality in the first year of treatment. It may also lead to a larger study prospectively assessing the effect of dialysis modality on cardiovascular morbidity and mortality.
ACTRN12609000049279.
接受腹膜透析和血液透析的患者动脉粥样硬化加速,心血管发病率和死亡率增加。动脉粥样硬化与动脉僵硬度增加、内皮功能障碍以及氧化应激和炎症加剧有关。本研究的目的是调查腹膜透析和血液透析对终末期肾病初发患者的动脉僵硬度、血管功能、心肌结构和功能、氧化应激及炎症的影响。
这是一项观察性研究。将招募80例5期慢性肾脏病患者并随访一年。主要结局指标包括:1)通过主动脉脉搏波速度测量的动脉僵硬度变化;2)通过血浆F2异前列腺素评估的氧化应激;3)通过血浆五聚素-3测量的炎症。次要结局将包括氧化应激和炎症的其他测量指标、使用肱动脉反应性技术评估的血管功能变化、颈动脉内膜中层厚度、增强指数,以及使用经胸超声心动图评估左心室几何形状、收缩和舒张功能。患者将在基线(开始透析治疗前6 - 8周)、开始透析后6个月和12个月接受这些测量。
本研究结果可能会指导治疗第一年透析方式的选择。它也可能会促成一项更大规模的前瞻性研究,评估透析方式对心血管发病率和死亡率的影响。
ACTRN12609000049279。